385 related articles for article (PubMed ID: 32292496)
1. Muscone/RI7217 co-modified upward messenger DTX liposomes enhanced permeability of blood-brain barrier and targeting glioma.
Kang S; Duan W; Zhang S; Chen D; Feng J; Qi N
Theranostics; 2020; 10(10):4308-4322. PubMed ID: 32292496
[No Abstract] [Full Text] [Related]
2. Combined integrin α
Qi N; Zhang S; Zhou X; Duan W; Gao D; Feng J; Li A
J Nanobiotechnology; 2021 Dec; 19(1):446. PubMed ID: 34949198
[TBL] [Abstract][Full Text] [Related]
3. "Guide" of muscone modification enhanced brain-targeting efficacy and anti-glioma effect of lactoferrin modified DTX liposomes.
Qi N; Duan W; Gao D; Ma N; Zhang J; Feng J; Li A
Bioeng Transl Med; 2023 Mar; 8(2):e10393. PubMed ID: 36925685
[TBL] [Abstract][Full Text] [Related]
4. Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model.
Salvati E; Re F; Sesana S; Cambianica I; Sancini G; Masserini M; Gregori M
Int J Nanomedicine; 2013; 8():1749-58. PubMed ID: 23674890
[TBL] [Abstract][Full Text] [Related]
5. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
[TBL] [Abstract][Full Text] [Related]
6. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals.
Ying X; Wen H; Lu WL; Du J; Guo J; Tian W; Men Y; Zhang Y; Li RJ; Yang TY; Shang DW; Lou JN; Zhang LR; Zhang Q
J Control Release; 2010 Jan; 141(2):183-92. PubMed ID: 19799948
[TBL] [Abstract][Full Text] [Related]
7. Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas.
Yang ZZ; Li JQ; Wang ZZ; Dong DW; Qi XR
Biomaterials; 2014 Jun; 35(19):5226-39. PubMed ID: 24695093
[TBL] [Abstract][Full Text] [Related]
8. A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood-brain barrier, and the transporting mechanism to glioma cells.
Liu C; Liu XN; Wang GL; Hei Y; Meng S; Yang LF; Yuan L; Xie Y
Int J Nanomedicine; 2017; 12():2407-2425. PubMed ID: 28405164
[TBL] [Abstract][Full Text] [Related]
9. Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes.
Gao JQ; Lv Q; Li LM; Tang XJ; Li FZ; Hu YL; Han M
Biomaterials; 2013 Jul; 34(22):5628-39. PubMed ID: 23628475
[TBL] [Abstract][Full Text] [Related]
10. Synergistic Combination of Doxorubicin and Paclitaxel Delivered by Blood Brain Barrier and Glioma Cells Dual Targeting Liposomes for Chemotherapy of Brain Glioma.
Chen X; Yuan M; Zhang Q; Ting Yang Y; Gao H; He Q
Curr Pharm Biotechnol; 2016; 17(7):636-50. PubMed ID: 27033513
[TBL] [Abstract][Full Text] [Related]
11. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
[TBL] [Abstract][Full Text] [Related]
12. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
[TBL] [Abstract][Full Text] [Related]
13. AS1411 Aptamer/Hyaluronic Acid-Bifunctionalized Microemulsion Co-Loading Shikonin and Docetaxel for Enhanced Antiglioma Therapy.
Wang H; Zhu Z; Zhang G; Lin F; Liu Y; Zhang Y; Feng J; Chen W; Meng Q; Chen L
J Pharm Sci; 2019 Nov; 108(11):3684-3694. PubMed ID: 31465736
[TBL] [Abstract][Full Text] [Related]
14. Large amino acid transporter 1 mediated glutamate modified docetaxel-loaded liposomes for glioma targeting.
Li L; Di X; Zhang S; Kan Q; Liu H; Lu T; Wang Y; Fu Q; Sun J; He Z
Colloids Surf B Biointerfaces; 2016 May; 141():260-267. PubMed ID: 26859117
[TBL] [Abstract][Full Text] [Related]
15. pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma.
Li M; Shi K; Tang X; Wei J; Cun X; Chen X; Yu Q; Zhang Z; He Q
Eur J Pharm Sci; 2018 Nov; 124():240-248. PubMed ID: 30071282
[TBL] [Abstract][Full Text] [Related]
16. Development of a hybrid nanocarrier-recognizing tumor vasculature and penetrating the BBB for glioblastoma multi-targeting therapy.
Fan R; Chuan D; Hou H; Chen H; Han B; Zhang X; Zhou L; Tong A; Xu J; Guo G
Nanoscale; 2019 Jun; 11(23):11285-11304. PubMed ID: 31165845
[TBL] [Abstract][Full Text] [Related]
17. Cell-permeable NF-κB inhibitor-conjugated liposomes for treatment of glioma.
Zhang Y; Zhang L; Hu Y; Jiang K; Li Z; Lin YZ; Wei G; Lu W
J Control Release; 2018 Nov; 289():102-113. PubMed ID: 30243823
[TBL] [Abstract][Full Text] [Related]
18. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
[TBL] [Abstract][Full Text] [Related]
19. Cell-Penetrating Peptide and Transferrin Co-Modified Liposomes for Targeted Therapy of Glioma.
Wang X; Zhao Y; Dong S; Lee RJ; Yang D; Zhang H; Teng L
Molecules; 2019 Sep; 24(19):. PubMed ID: 31574945
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting.
Liu Y; Ran R; Chen J; Kuang Q; Tang J; Mei L; Zhang Q; Gao H; Zhang Z; He Q
Biomaterials; 2014 Jun; 35(17):4835-47. PubMed ID: 24651033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
